We are at The EBMT Annual Meeting where we will highlight data from our #oncology portfolio, including results in chronic graft-versus-host disease ( #GVHD ). #EBMT24

This #WorldHealthDay , Steven Stein, Chief Medical Officer at Incyte, shares his perspective on the work Incyte is doing to advance health for patients with critical medical needs. To learn more about how we support patients, visit our website. #SolveOn

Congratulations to our CEO, Hervé Hoppenot, for being recognized as an inaugural Delaware 222 Honoree by DelawareBizTimes! His leadership has made a significant impact and this recognition highlights his influential role in Delaware's business community.

Pamella Galluzzi de Castro and Susan Spitz have been honored with the prestigious HBAnet Rising Star and Luminary awards, respectively. Congratulations to Pamella and Susan for their dedication to #SolveOn and their profound impact on patients’ lives. #HBAImpact #HBAWOTY24

At #AAD2024 , we presented data of our research in prurigo nodularis (PN), a chronic inflammatory skin disease where an extremely itchy, symmetrically distributed rash appears on certain parts of the body. How much do you know about prurigo nodularis?

#News : Late-breaking data from our Phase 2 study focused on an investigational therapy for patients with prurigo nodularis has been presented today at @AADSkin. Learn more. #AAD2024 bit.ly/3PeB3jW

Today at the @AADSkin Annual Meeting, we are excited to share data from our Phase 2 study for an investigational treatment option for patients with hidradenitis suppurativa. Learn more. #AAD2024 bit.ly/3ItE7VF

Incyte is proud to participate at the @AADSkin Annual Meeting showcasing our significant contributions to the field of dermatology. Hear more about Incyte's commitment from Jim Lee, Group Vice President, Head Inflammation and AutoImmunity.

On #InternationalWomensDay , we celebrate the significant achievements of women around the world and the perspectives of #TeamIncyte . We are committed to supporting ongoing efforts to #InspireInclusion in the workplace. #IWD2024 #SolveOn

Pablo Cagnoni, President and Head of Research & Development at Incyte, speaks to Incyte data presentations at the @AADSkin Annual Meeting and our progressing Dermatology portfolio. Learn more.

We’re presenting at the @AADSkin Annual Meeting! Learn more about our #dermatology portfolio and research being shared this weekend. #AAD2024

#News : Multiple abstracts from our growing dermatology portfolio will be presented at the AAD Annual Meeting. #AAD2024 bit.ly/49AdVEI

To our incredible team: Thank you for your hard work and dedication. Every day, you bring your best, push boundaries and contribute to impacting the lives of patients. #EmployeeAppreciationDay #SolveOn

We’re proud to raise awareness of rare diseases like myeloproliferative neoplasms ( #MPNs ). This #RareDiseaseDay , we’re helping make #TheUnseenJourney of symptoms seen through generative AI. Learn more at bit.ly/49vfvYn.

#RareDiseaseDay reminds us of our commitment to find innovative solutions for patients. Our scientists work tirelessly to make meaningful discoveries, regardless of the disease or size of the patient population. #SolveOn ForPatients #SolveOn

#News : The U.S. FDA has accepted for Priority Review the Biologics License Application for a potentially differentiated treatment for chronic graft-versus-host disease ( #GVHD ). Learn more. bit.ly/3OZ1Lgq

On #NationalCaregiversDay we honor those who selflessly, generously and compassionately care for people with complex diseases. Watch Pedro and Jessica talk about their heroes. #SolveOn ForPatients #SolveOn

This #BlackHistoryMonth , we proudly shine a light on the remarkable individuals from #TeamIncyte who are part of the National Pan-Hellenic Council (NPHC), also known as the Divine Nine. Together, we honor the past, embrace the present and shape a brighter future.

Introducing the ChOLLECTIVE: an initiative that amplifies the voice of the cholangiocarcinoma ( #CCA ) community and brings people together through shared experiences. Watch Karli and Matt’s inspiring story. #WorldCCADay #SolveOn ForPatients #SolveOn

We’ve reported our Q4 and year-end 2023 financial results and provided updates on key clinical programs. Learn more. bit.ly/49f3w0O